This inventor holds 4 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignee: Stallergenes. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: The Innovative Contributions of Inventor Véronique Bodo
Introduction: Véronique Bodo, a notable inventor based in Palaiseau, France, has made significant strides in the field of immunotherapy. With a total of four patents to his name, Bodo's work primarily focuses on understanding immune responses and enhancing the efficacy of allergen immunotherapy.
Latest Patents: Among his latest inventions is the patent titled "IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy." This innovative approach utilizes IL-10 as a biological marker to predict how well a patient allergic to house dust mites will respond to immunotherapy. Another remarkable patent he has developed deals with "Markers of immune response," which outlines methods to ascertain whether a dendritic cell is of the type 2 or tolerogenic nature. This invention also describes techniques for determining the patient's immune response during immunotherapy or after vaccination, thus providing essential insights into treatment effectiveness.
Career Highlights: Véronique Bodo's career highlights include his role at Stallergenes, a leader in allergen immunotherapy. His expertise and innovations in the field have not only contributed to his company's success but have also advanced the understanding of allergic responses and treatment modalities.
Collaborations: Throughout his career, Bodo has collaborated with esteemed colleagues, including Philippe Moingeon and Emmanuel Nony. These partnerships have enriched his research and have been instrumental in driving forward the development of his patents and innovations.
Conclusion: As an inventor, Véronique Bodo exemplifies dedication to improving healthcare through innovative solutions. His patents, particularly in the realm of immunotherapy, pave the way for more personalized and effective treatment strategies for allergy sufferers. The impact of his work resonates well beyond his immediate contributions, promising advancements in patient care and immunological research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile